GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Akerna Corp (NAS:KERN) » Definitions » Days Sales Outstanding

Akerna (Akerna) Days Sales Outstanding : 11.02 (As of Sep. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Akerna Days Sales Outstanding?

Akerna's average Accounts Receivable for the three months ended in Sep. 2023 was $0.25 Mil. Akerna's Revenue for the three months ended in Sep. 2023 was $2.08 Mil. Hence, Akerna's Days Sales Outstanding for the three months ended in Sep. 2023 was 11.02.

The historical rank and industry rank for Akerna's Days Sales Outstanding or its related term are showing as below:

KERN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 20.72   Med: 35.36   Max: 45.27
Current: 21.48

During the past 6 years, Akerna's highest Days Sales Outstanding was 45.27. The lowest was 20.72. And the median was 35.36.

KERN's Days Sales Outstanding is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 46.87 vs KERN: 21.48

Akerna's Days Sales Outstanding declined from Sep. 2022 (48.44) to Sep. 2023 (11.02).


Akerna Days Sales Outstanding Historical Data

The historical data trend for Akerna's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akerna Days Sales Outstanding Chart

Akerna Annual Data
Trend Dec17 Dec18 Jun19 Jun20 Dec21 Dec22
Days Sales Outstanding
Get a 7-Day Free Trial - 42.39 45.27 28.33 20.72

Akerna Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.44 32.80 17.79 11.77 11.02

Competitive Comparison of Akerna's Days Sales Outstanding

For the Health Information Services subindustry, Akerna's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Akerna's Days Sales Outstanding Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Akerna's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Akerna's Days Sales Outstanding falls into.



Akerna Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Akerna's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

Days Sales Outstanding (A: Dec. 2022 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2021 ) + Accounts Receivable (A: Dec. 2022 )) / count ) / Revenue (A: Dec. 2022 )*Days in Period
=( (0.874 + 0.675) / 2 ) / 13.645*365
=0.7745 / 13.645*365
=20.72

Akerna's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

Days Sales Outstanding (Q: Sep. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Sep. 2023 )) / count ) / Revenue (A: Sep. 2023 )*Days in Period
=( (0.25 + 0.253) / 2 ) / 2.083*365 / 4
=0.2515 / 2.083*365 / 4
=11.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Akerna  (NAS:KERN) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Akerna Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Akerna's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Akerna (Akerna) Business Description

Traded in Other Exchanges
N/A
Address
1550 Larimer Street, No 246, Denver, CO, USA, 80202
Akerna Corp is a United States-based company provider of enterprise software solutions within the cannabis industry. It offers MJ Platform and Leaf Data Systems which are platforms that provide clients and government entities with a central data management system for tracking regulated cannabis products from seed to product to shelf to customers through the supply chain. It has two sources of revenue software and consulting services, and the majority of the revenue comes from commercial software platforms.
Executives
Mj Bridge Co., Inc. 10 percent owner 16192 COASTAL HIGHWAY, LEWES DE 19958
Barry Fishman director C/O AKERNA CORP., 1550 LARIMER STREET, SUITE 246, DENVER CO 80202
Matthew Ryan Kane director AKERNA CORP., 1601 ARAPAHOE ST., DENVER CO 80202
Thompson Cecil Ray Jr officer: Chief Operating Officer 1630 WELTON ST, SUITE 400, DENVER CO 80201
David R Mccullough officer: Chief Technology Officer C/O AKERNA CORP., 1630 WELTON STREET - 4TH FLOOR, DENVER CO 80202
Jessica Billingsley director, 10 percent owner, officer: Chief Executive Officer AKERNA CORP., 1601 ARAPAHOE ST., DENVER CO 80202
Amy A. Poinsett Revocable Living Trust 10 percent owner 601 16TH STREET, SUITE C-420, GOLDEN CO 80403
Fowle John Michael Jr officer: Chief Financial Officer AKERNA CORP., 1601 ARAPAHOE ST., DENVER CO 80202
Tahira Rehmatullah director C/O AKERNA CORP., 1601 ARAPAHOE STREET, DENVER CO 32836
Ashesh C Shah director AKERNA CORP., 1601 ARAPAHOE ST., DENVER CO 80202
Nina Simosko officer: Chief Revenue Officer AKERNA CORP., 1601 ARAPAHOE ST., DENVER CO 80202
Scott Sozio director BAY HARBOUR MANAGEMENT, 885 THIRD AVENUE, 34TH FLOOR, NEW YORK NY 10022
Jessica Billingsley Living Trust 10 percent owner 1601 ARAPAHOE STREET, DENVER CO 80202
Amy A. Poinsett 10 percent owner 601 16TH STREET, SUITE C-420, GOLDEN CO 80401
Mtech Sponsor Llc 10 percent owner 10124 FOXHURST CT, ORLANDO FL 32836

Akerna (Akerna) Headlines